Talking Science with Nonscientists: A Personal Communication

I remember it clearly. It was a warm Friday evening in August. I stood with a beer in my hand, making small talk at a graduate school party. It wasn't long before a new acquaintance, a student of ethnic music, asked, "What does an organic chemist do?" "Mmm ...," I muttered. I stared intently at my beer, swirled it a bit, and wished fervently for a napkin, a ballpoint pen, and a hard, clear surface to write on. But ... no. Complex drawings and scattershot arrows wouldn't interest her, and I'd h

Written byJames Kling
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

I remember it clearly. It was a warm Friday evening in August. I stood with a beer in my hand, making small talk at a graduate school party. It wasn't long before a new acquaintance, a student of ethnic music, asked, "What does an organic chemist do?"

"Mmm ...," I muttered. I stared intently at my beer, swirled it a bit, and wished fervently for a napkin, a ballpoint pen, and a hard, clear surface to write on. But ... no. Complex drawings and scattershot arrows wouldn't interest her, and I'd have lost before I connected the first line.

"It's a little like the Legos you played with when you were a kid--you find different ways to construct molecules," I eventually decided. There--I detected a spark of interest. You can talk science face to face with a lay audience and make it interesting. But it's a bit different from presenting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies